DG Capital Management, LLC 13D and 13G filings for Fennec Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:06 pm Sale |
2024-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC |
DG Capital Management, LLC | 1,114,692 4.100% |
-407,512 (-26.77%) |
Filing |
| 2024-11-12 7:38 pm Purchase |
2024-09-30 | 13G | Fennec Pharmaceuticals Inc. FENC |
DG Capital Management, LLC | 1,522,204 5.500% |
105,748 (+7.47%) |
Filing |
| 2024-06-27 4:43 pm Purchase |
2024-05-14 | 13G | Fennec Pharmaceuticals Inc. FENC |
DG Capital Management, LLC | 1,416,456 5.200% |
1,416,456 (New Position) |
Filing |